IPO Timeline
Broker Results (T-2)
2023-09-26
Some brokers release in afternoon
Grey Market (T-1)
2023-09-27
Afternoon
HKEX Allotment (T-1)
2023-09-27
Evening
Registrar Allotment (T-1)
2023-09-27
Evening
Listing Day (T)
2023-09-28
First day of trading
Company Overview
| Stock Name | 东软熙康 |
|---|---|
| Stock Code | 09686 |
| Company Full Name | 东软熙康 |
| Industry | 軟件服務 |
| Principal Activities | 公司打造了中國首個以城市為入口的云醫院平臺，并建立了一個云醫院網絡，將地方政府、醫療機構、患者及保險公司聯系起來，以實現公平地獲取醫療資源并更有效及高效地交付醫療服務。 |
| Listing Date | 2023-09-28 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國浙江省寧波市海曙區惠政巷12號1-1，1-2，1-3，1-4，1-5，2-1 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.xikang.com/ |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 4.76 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 34.8% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 57,098,580 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 500 | HK$ 2,380 |
| 2 lots | 1,000 | HK$ 4,760 |
| 3 lots | 1,500 | HK$ 7,140 |
| 4 lots | 2,000 | HK$ 9,520 |
| 5 lots | 2,500 | HK$ 11,900 |
| 6 lots | 3,000 | HK$ 14,280 |
| 7 lots | 3,500 | HK$ 16,660 |
| 8 lots | 4,000 | HK$ 19,040 |
| 9 lots | 4,500 | HK$ 21,420 |
| 10 lots | 5,000 | HK$ 23,800 |
| 12 lots | 6,000 | HK$ 28,560 |
| 14 lots | 7,000 | HK$ 33,320 |
| 16 lots | 8,000 | HK$ 38,080 |
| 18 lots | 9,000 | HK$ 42,840 |
| 20 lots | 10,000 | HK$ 47,600 |
| 30 lots | 15,000 | HK$ 71,400 |
| 40 lots | 20,000 | HK$ 95,200 |
| 50 lots | 25,000 | HK$ 119,000 |
| 60 lots | 30,000 | HK$ 142,800 |
| 70 lots | 35,000 | HK$ 166,600 |
| 80 lots | 40,000 | HK$ 190,400 |
| 100 lots | 50,000 | HK$ 238,000 |
| 120 lots | 60,000 | HK$ 285,600 |
| 160 lots | 80,000 | HK$ 380,800 |
| 180 lots | 90,000 | HK$ 428,400 |
| 200 lots | 100,000 | HK$ 476,000 |
| 400 lots | 200,000 | HK$ 952,000 |
| 800 lots | 400,000 | HK$ 1,904,000 |
| 1,000 lots | 500,000 | HK$ 2,380,000 |
Pool B
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 4,000 lots | 2,000,000 | HK$ 9,520,000 |
| 6,000 lots | 3,000,000 | HK$ 14,280,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 2.72 |
|---|---|
| First Day Open | HK$ 3.69 |
| First Day Change | -42.86% |
| First Day Volume | 6301000.0 |
| First Day Turnover | 20936700.0 |
Use of Proceeds
| Use of Proceeds | 1、約30%或166.3百萬港元，將用于拓展以城市為入口的云醫院平臺，以擴大我們的醫療網絡及用戶群； 2、約25%或138.6百萬港元，將用于豐富我們在整個行業價值鏈上的產品，以提供更專業及多樣化的醫療健康服務； 3、約25%或138.6百萬港元，將用于技術基礎設施及數據處理能力的研發； 4、約10%或55.4百萬港元，在未來3至5年，將用于潛在的并購機會； 5、約10%或55.4百萬港元，將用于營運資金及其他一般公司用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
中国国际金融香港证券有限公司 CE AEN894
Overall Coordinators (2)
中国国际金融香港证券有限公司 CE AEN894
华盛资本证券有限公司 CE AUL711
Joint Bookrunners (7)
中国国际金融香港证券有限公司 CE AEN894
华盛资本证券有限公司 CE AUL711
大和资本市场香港有限公司 CE AAB639
中银国际亚洲有限公司 CE AET863
富途证券国际（香港）有限公司 CE AZT137
中国银河国际证券（香港）有限公司 CE AXM459
GF Securities (Hong Kong) Brokerage Limited CE AOB364
Joint Lead Managers (7)
中国国际金融香港证券有限公司 CE AEN894
华盛资本证券有限公司 CE AUL711
大和资本市场香港有限公司 CE AAB639
中银国际亚洲有限公司 CE AET863
富途证券国际（香港）有限公司 CE AZT137
中国银河国际证券（香港）有限公司 CE AXM459
GF Securities (Hong Kong) Brokerage Limited CE AOB364
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | INFO EXPERT SERVICES LIMITED | 101,883,040 HKD | — | 16.00% | — | 6 months | 2024-03-28 |
| 2 | 宁波海曙产业投资有限公司 | 59,947,440 HKD | — | 9.41% | — | 6 months | 2024-03-28 |
| 3 | 宁波市产业发展基金有限公司 | 59,947,440 HKD | — | 9.41% | — | 6 months | 2024-03-28 |
Directors & Management
| Chairman | 劉積仁 |
|---|---|
| Company Secretary | 趙姝;黃偉超 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 東軟(香港)有限公司(23.66%);中國人民財產保險股份有限公司(12.12%);景建創投有限公司(10.30%);斯邁威控股有限公司(9.09%);東控國際第五投資有限公司(8.12%);第一關愛(7.69%);Syn Invest Co. Ltd(5.05%) |
|---|
Subscription Tiers
IPO Timeline
